The civic record
Read. Follow. Verify.Delaware expands audit protections, appeals timelines, and contract notice rules for pharmacies regulated under pharmacy benefits managers
Last action · September 8, 2026: Signed by GovernorSponsors: Dave Sokola and 11 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
Delaware enacts SB 271 to strengthen procedural protections for pharmacies, pharmacists, and consumers interacting with s by increasing the reimbursement appeal window from 10 to 40 days, mandating 60 days' notice before contract amendments, and limiting audits to once every 12 months.
Changes financial and operational oversight rules for pharmacies and s operating in the state, altering audit cost responsibilities, reporting frequencies, and consumer data-sharing restrictions.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Pharmacies
Pharmacies receive extended appeal windows, mandatory audit notice timelines, and protection from retaliatory actions by pharmacy benefits managers.
Pharmacy benefits managers
Pharmacy benefits managers must comply with annual reporting rules, cover all audit costs, provide 60-day contract amendment notices, and restrict commercial data sharing.
Consumers
Consumers receive enhanced procedural protections and limits on out-of-pocket costs regarding therapeutically equivalent alternative drug requirements.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
How much time do pharmacies have to appeal a reimbursement amount under the new law?
Who bears the cost of a wholesale invoice audit under this legislation?
How often must pharmacy benefits managers file rebate reports?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Current status: Signed into law.
Procedural history
9 actions- Sep 8, 2026Office of the GovernorEnrolledSigned by Governor
- Jun 24, 2026HouseFloorPassed By House. Votes: 40 YES 1 ABSENT
- Jun 16, 2026HouseCommitteeReported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 1 Favorable, 9 On Its Merits
- Jun 10, 2026HouseIntroducedAssigned to Economic Development/Banking/Insurance & Commerce Committee in House
- Jun 9, 2026SenateFloorPassed By Senate. Votes: 20 YES 1 ABSENT
- Jun 9, 2026SenateCommitteeAmendment SA 1 to SB 271 - Passed By Senate. Votes: 20 YES 1 ABSENT
Show 3 earlier actions
- Jun 9, 2026SenateCommitteeAmendment SA 1 to SB 271 - Introduced and Placed With Bill
- May 21, 2026SenateCommitteeReported Out of Committee (Executive) in Senate with 6 On Its Merits
- Mar 26, 2026SenateIntroducedIntroduced and Assigned to Executive Committee in Senate
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Voting Record
SM
Total
40
- Yes
- 40
- No
- 0
- Present
- 0
- Not voting
- 0
- Abstain
- 0
How they voted (40)
16 more members
Show 1 earlier roll call
SM
Total
20
- Yes
- 20
- No
- 0
- Present
- 0
- Not voting
- 0
- Abstain
- 0
How they voted (20)
Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Show 7 more sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Transition to Annual Rebate Reporting
The state shifted reporting requirements for rebates from quarterly to annual filings to reduce inaccuracies associated with aggregated contract periods.
Connected Entities
Sources
legis.delaware.gov
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy40Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz30Current news / social attention level
Publisher tools